Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Adams, A. Charlett, W. Edmunds, G. Hughes (2004)
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studiesSexually Transmitted Infections, 80
H. Wiesenfeld, S. Hillier, M. Krohn, D. Landers, R. Sweet (2003)
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 5
H. Weiss (2004)
Epidemiology of herpes simplex virus type 2 infection in the developing world.Herpes : the journal of the IHMF, 11 Suppl 1
M. Wawer, R. Gray, N. Sewankambo, D. Serwadda, L. Paxton, S. Berkley, D. McNairn, F. Wabwire-mangen, Chuanjun Li, F. Nalugoda, N. Kiwanuka, T. Lutalo, R. Brookmeyer, R. Kelly, T. Quinn (1998)
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, UgandaAIDS, 12
H. Grosskurth, F. Mosha, J. Todd (1995)
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: ra
A. Nilsen, H. Myrmel (2000)
Changing trends in genital herpes simplex virus infection in Bergen, NorwayActa Obstetricia et Gynecologica Scandinavica, 79
A. Rebbapragada, C. Wachihi, C. Pettengell, Sherzana Sunderji, S. Huibner, W. Jaoko, B. Ball, K. Fowke, T. Mazzulli, F. Plummer, R. Kaul (2007)
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tractAIDS, 21
A. Kamali, J. Kinsman, N. Nalweyiso, K. Mitchell, E. Kanyesigye, J. Kengeya‐Kayondo, L. Carpenter, A. Nunn, J. Whitworth (2002)
A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findingsTropical Medicine & International Health, 7
E. BeatriceHervé (2003)
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Cherpes T L, Meyn L A, Krohn M A, Lurie J G, Hillier S L. Clin Infect Dis 2003 (1 August); 37: 319-25.Revista Chilena De Infectologia, 20
E. Corbett, R. Hayes, Dsc, R. Steketee, F. Kuile, E. Corbett, R. Steketee, F. Kuile, A. Latif, A. Kamali, R. Hayes
For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Hiv-1/aids and the Control of Other Infectious Diseases in Africa
J. Schwebke, R. Desmond (2007)
A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 2
(1998)
pre - vention , Rakai , Uganda
A. Wald (2004)
Herpes simplex virus type 2 transmission: risk factors and virus shedding.Herpes : the journal of the IHMF, 11 Suppl 3
L. Corey, A. Wald, C. Celum, T. Quinn (2004)
The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping EpidemicsJAIDS Journal of Acquired Immune Deficiency Syndromes, 35
R. Kaul, J. Kimani, N. Nagelkerke, K. Fonck, E. Ngugi, F. Keli, K. MacDonald, I. Maclean, J. Bwayo, M. Temmerman, A. Ronald, S. Moses (2004)
Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.JAMA, 291 21
S. Hedges, Frank Barrientes, R. Desmond, J. Schwebke (2006)
Local and systemic cytokine levels in relation to changes in vaginal flora.The Journal of infectious diseases, 193 4
J. Mosca, D. Bednarik, N. Raj, C. Rosen, J. Sodroski, W. Haseltine, G. Hayward, P. Pitha (1987)
Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.Proceedings of the National Academy of Sciences of the United States of America, 84 21
R. Kaul, J. Kimani, N. Nagelkerke, K. Fonck, F. Keli, K. MacDonald, A. Ronald, F. Plummer, J. Bwayo, E. Ngugi, M. Temmerman, S. Moses (2002)
Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya.Journal of acquired immune deficiency syndromes, 30 1
R. Kaul, J. Kimani, F. Plummer, J. Bwayo, R. Brunham, E. Ngugi (1997)
Risk Factors for Genital Ulcerations in Kenyan Sex Workers: The Role of Human Immunodeficiency Virus Type 1 InfectionSexually Transmitted Diseases, 24
A. Ouedraogo, N. Nagot, L. Vergne, I. Konaté, H. Weiss, M. Defer, V. Foulongne, A. Sanon, J. Andonaba, M. Segondy, P. Mayaud, P. Perre (2006)
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trialAIDS, 20
T. Cherpes, L. Meyn, M. Krohn, Joel Lurie, S. Hillier (2003)
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 3
A. Wald, L. Corey (2003)
How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?The Journal of infectious diseases, 187 10
C. Cohen, F. Plummer, N. Mugo, I. Maclean, Caixia Shen, E. Bukusi, E. Irungu, S. Sinei, J. Bwayo, R. Brunham (1999)
Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?AIDS, 13 3
K. Tomecki (1996)
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial: Grosskurth J, Mosha F, Todd J, et al. Lancet 1995;346:530–536Journal of The American Academy of Dermatology, 35
E. Freeman, H. Weiss, J. Glynn, P. Cross, J. Whitworth, R. Hayes (2006)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studiesAIDS, 20
C. Celum, N. Robinson, M. Cohen (2005)
Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.The Journal of infectious diseases, 191 Suppl 1
M. Yudin, D. Landers, L. Meyn, S. Hillier (2003)
Clinical and Cervical Cytokine Response to Treatment With Oral or Vaginal Metronidazole for Bacterial Vaginosis During Pregnancy: A Randomized TrialObstetrics & Gynecology, 102
Petra Muenzner, M. Naumann, T. Meyer, S. Gray-Owen (2001)
Pathogenic Neisseria Trigger Expression of Their Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1 (CEACAM1; Previously CD66a) Receptor on Primary Endothelial Cells by Activating the Immediate Early Response Transcription Factor, Nuclear Factor-κB*The Journal of Biological Chemistry, 276
Background. Prevalent herpes simplex virus type 2 (HSV-2) infection increases human immunodeficiency virus acquisition. We hypothesized that HSV-2 infection might also predispose individuals to acquire other common sexually transmitted infections (STIs).Methods. We studied the association between prevalent HSV-2 infection and STI incidence in a prospective, randomized trial of periodic STI therapy among Kenyan female sex workers. Participants were screened monthly for infection with Neisseria gonorrhoeae and Chlamydia trachomatis, and at least every 6 months for bacterial vaginosis (BV) and infection with Treponema pallidum, Trichomonas vaginalis, and/or HSV-2.Results. Increased prevalence of HSV-2 infection and increased prevalence of BV were each associated with the other; the direction of causality could not be determined. After stratifying for sexual risk-taking, BV status, and antibiotic use, prevalent HSV-2 infection remained associated with an increased incidence of infection with N. gonorrhoeae (incidence rate ratio [IRR], 4.3 [95% confidence interval {CI}, 1.5–12.2]), T. vaginalis (IRR, 2.3 [95% CI, 1.3–4.2]), and syphilis (IRR, 4.7 [95% CI, 1.1–19.9]). BV was associated with increased rates of infection with C. trachomatis (IRR, 2.1 [95% CI, 1.1–3.8]) and T. vaginalis (IRR, 8.0 [95% CI, 3.2–19.8]).Conclusion. Increased prevalences of HSV-2 infection and BV were associated with each other and also associated with enhanced susceptibility to an overlapping spectrum of other STIs. Demonstration of causality will require clinical trials that suppress HSV-2 infection, BV, or both.
Journal of Infectious Diseases – Oxford University Press
Published: Dec 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.